Miltenyi Biotec GmbH
Originally published online as doi:10.1189/jlb.1208742 on April 24, 2009

Published online before print April 24, 2009
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
jlb.1208742v1
86/2/229    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liang, X.
Right arrow Articles by Warren, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, X.
Right arrow Articles by Warren, H. S.
Related Collections
Right arrowRelated Article
(Journal of Leukocyte Biology. 2009;86:229-235.)
© 2009 Society for Leukocyte Biology

Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages

Xueya Liang*,1, Tian Lin*,1, Guangjie Sun*, Laura Beasley-Topliffe*, Jean-Marc Cavaillon{dagger} and H. Shaw Warren*,2

* Infectious Disease Unit, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA; and
{dagger} Unit of Cytokines and Inflammation, Institute Pasteur, Paris, France

2. Correspondence: Infectious Disease Unit, Massachusetts General Hospital East, 149 13th St., Charlestown, MA 02129, USA. E-mail: swarren1{at}partners.org

ABSTRACT

Detection of LPS in tissues is an integral component of innate immunity that acts to protect against invasion by Gram-negative bacteria. Plasma down-regulates LPS-induced cytokine production from macrophages, thereby limiting systemic inflammation in blood and distant tissues. To identify the protein(s) involved in this process, we used classical biochemical chromatographic techniques to identify fractions of mouse sera that suppress LPS-induced TNF from bone marrow-derived macrophages (BMDMs). Fractionation yielded microgram quantities of a protein that was identified by MS to be hemopexin (Hx). Mouse Hx purified on hemin-agarose beads and rhHx decreased the production of cytokines from BMDMs and peritoneal macrophages induced by LPS. Preincubation of LPS with Hx did not affect the activity of LPS on LAL, whereas preincubation of Hx with macrophages followed by washing resulted in decreased activity of these cells in response to LPS, suggesting that Hx acts on macrophages rather than LPS. Heme-free Hx did not stimulate HO-1 in the macrophages. Purified Hx also decreased TNF and IL-6 from macrophages induced by the synthetic TLR2 agonist Pam3Cys. Our data suggest that Hx, which is an acute-phase protein that increases during inflammation, limits TLR4 and TLR2 agonist-induced macrophage cytokine production directly through a mechanism distinct from HO-1.

Key Words: TLR • agonist • serum • Pam3Cys • innate immunity


Related Article

Editorial: Hemopexin: newest member of the anti-inflammatory mediator club
Mitchell P. Fink
J. Leukoc. Biol. 2009 86: 203-204. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Z. Yang, J. D. Philips, R. T. Doty, P. Giraudi, J. D. Ostrow, C. Tiribelli, A. Smith, and J. L. Abkowitz
Kinetics and Specificity of Feline Leukemia Virus Subgroup C Receptor (FLVCR) Export Function and Its Dependence on Hemopexin
J. Biol. Chem., September 10, 2010; 285(37): 28874 - 28882.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Duan, R. Davis, E. L. Sadat, J. Collins, P. C. Sternweis, D. Yuan, and L. I. Jiang
Distinct Roles of Adenylyl Cyclase VII in Regulating the Immune Responses in Mice
J. Immunol., July 1, 2010; 185(1): 335 - 344.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
W. W. Bakker, B. N. Melgert, and M. M. Faas
Hemopexin: anti-inflammatory, pro-inflammatory, or both?
J. Leukoc. Biol., January 1, 2010; 87(1): 1 - 2.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. S. Warren and T. Lin
Response to letter by Bakker et al.
J. Leukoc. Biol., January 1, 2010; 87(1): 3 - 3.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. P. Fink
Reply to letter by Bakker et al.
J. Leukoc. Biol., January 1, 2010; 87(1): 5 - 5.
[Full Text] [PDF]